Startups are private companies, but once they IPO they become "public"...meaning the average person has more access to their financials. In the case of Ginkgo Bioworks, it hasn't generated as much revenue as anticipated, but still has a ton of money in the bank to work on different projects (see the news article on ChatGPT for DNA). It'll be important to monitor its performance over the coming months and years to see how the company evolves considering its previous financial performances, but its definitely working on some really cool initiatives that have implications across healthcare, pharma, food, and more. (November 2023)